Novo Nordisk Shares Rise After Regulatory Approval of Catalent Deal
Daily NewsInvesting.com -- Shares of Novo Nordisk (NYSE:NVO) rose by 2% today after the company announced that all regulatory closing conditions for its pending transaction...
Read More